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Abstract 
Peri-implant diseases are a cluster of “contemporary” oral infections in humans that 
have emerged as a result of the routine application of osseointegrated dental implants 
in clinical practice. They are characterized by the inflammatory destruction of the 
implant-supporting tissues, as a result of biofilm formation on the implant surface. Peri-
implant mucositis and peri-implantitis are analogous to gingivitis and periodontitis that 
affect natural teeth. The aim of this comprehensive review was to provide insights into 
the infectious aetiology and immuno-pathology of peri-implant diseases, and to identify 
similarities and differences with periodontal diseases. The microbial composition of peri-
implantitis-associated biofilms is mixed, non-specific and very similar to that of 
periodontitis. A considerable exception is the frequent presence of high numbers of 
staphylococci and enteric bacteria in peri-implantitis. The sequence of immuno-
pathological events and the qualitative composition of the immune cells in peri-implant 
infections are similar to that of periodontal infections. The lesions are characterized 
predominantly by neutrophils, macrophages, T- and B-cells. Nevertheless, compared to 
periodontitis, peri-implantitis is marked by a more extensive inflammatory infiltrate and 
innate immune response, a greater severity of tissue destruction and a faster 
progression rate. This could well account for the structural differences between the two 
tissue types, predominantly the lack of periodontal ligament and Sharpey’s fibres 
around implants. In order to support the early diagnosis and prevention of peri-
implantitis, it is crucial to explain its fast progression rate by elucidating the underlying 
molecular mechanisms. This could be achieved, for instance, by utilizing the non-
invasive collection and analysis of peri-implant crevicular fluid. 
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Oral ecology and biofilm formation 
The oral cavity is a dynamic ecosystem continuously colonized by microorganisms 
which are collectively defined as the oral microbial flora. These have evolved along with 
the host, and their growth is dependent on the available nutrients and their capacity to 
withstand local immune defenses. Bacteria grow on natural (tooth, mucosa) or artificial 
(prostheses, implants) surfaces as biofilms, which are highly organized and structured 
microbial communities, embedded in polymeric matrices. As part of a biofilm 
community, bacteria become more virulent than their planktonic forms and less 
penetrable by elements of the immune system, such as neutrophils and antibodies, or 
antimicrobial factors (1). The contemporary notion on how oral biofilms are causing oral 
diseases, such as caries, periodontitis, or peri-implantitis is well summarized by the 
“ecological plaque hypothesis” (2). According to this hypothesis, it is the 
interrelationship between the bacteria and the host response that defines health or 
disease. Changes in the local microenvironment may shift the composition of the biofilm 
microflora. Under the newly established conditions, the predominant microbial species 
may display enhanced virulence and act as opportunistic pathogens, causing disease to 
susceptible hosts. Thus, oral infections are considered to be endogenous infections. 
 
Clinical characteristics of peri-implant diseases 
Osseointegrated dental implants are metallic devices made predominantly of titanium 
that are surgically implanted into the jaw bone, substituting one or more missing teeth. A 
prosthetic restoration is then fit on a transmucosal abutment structure, aiming to restore 
the functional and aesthetic needs of that site of the oral cavity. Nevertheless, the 
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artificial manufactured surfaces of dental implants are also prone to microbial 
colonization and biofilm formation, eventually causing infection of the implant-supporting 
(peri-implant) tissues. 
Failures of dental implant function can be classified either as early, or as late 
ones (3, 4). Early implant failures are the ones that occur due to incomplete 
osseointegration, before or after the functional loading of the implant. Such failures 
include early loading, surgical contamination, poor compatibility of the implanted 
material, or inefficient healing. On the other hand, late failures involve disruption of the 
function of an already osseointegrated implant, mainly due to chronic infection of the 
peri-implant tissues. In peri-implant mucositis, the biofilm-induced inflammation is 
localized on the soft peri-implant mucosa, with no evidence of destruction of the 
supporting bone. In peri-implantitis, the inflammation expands deeper into the bone 
tissue, leading to its gradual destruction, and eventually to implant loss. These two 
forms of peri-implant disease are analogous to gingivitis and periodontitis of natural 
teeth (5). 
The diagnostic criteria for peri-implant diseases are mainly clinical and 
radiographic (6). Peri-implant mucositis is characterized by inflamed or erythematous 
mucosa and bleeding during the examination. Peri-implantitis is further characterized by 
the formation of a peri-implant pocket greater than 4 mm, bleeding or suppuration on 
probing, and, radiographically, a characteristic symmetrical “saucer-shaped” bone 
destruction (or “crater”) around the implant. Mobility can occur at progressed stages and 
is associated with poor prognosis of the implant. The increased probing depth, the 
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positive bleeding on probing and the presence of suppuration in particular are important 
diagnostic indicators of peri-implant diseases (7).  
The consensus risk factors for peri-implantitis are poor oral hygiene, smoking, 
systemic conditions (e.g. diabetes mellitus), genetic susceptibility, potentially alcohol 
consumption, and prior history of periodontitis (7). The first four are shared in common 
with periodontitis, whereas the last one denotes an increased susceptibility to local oral 
infection. Hence, there appears to be a parallel trend between periodontal and peri-
implant diseases. 
 
Aetiology and pathogenesis of peri-implant diseases 
There are two crucial steps in understanding the infectious aetiology and pathogenesis 
of peri-implant diseases: understanding of a) the aetiological factors and pathogenic 
mechanisms that govern periodontal diseases, and b) the structural and immuno-
pathological differences between periodontal and peri-implant tissues. In other terms, 
the already established knowledge on periodontal diseases should be a starting point 
for deciphering in peri-implant diseases, keeping well in view that any identified 
differences between the two could yield independent research questions. 
 
Differences between periodontal and peri-implant tissues 
Although there are in principle clinical and histopathological similarities between the 
periodontal and peri-implant mucosa, there are also some fundamental differences (5). 
The main one is the absence of Sharpey’s fibres inserting perpendicularly to the implant 
surface, as opposed to the cementum of natural teeth. Instead, the collagen fibers of the 
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submucosal connective tissue are arranged parallel to implant surface. This results in 
the peri-implant crevice being deeper than the gingival crevice, eventually allowing the 
deeper penetration of bacteria. In terms of the interface with the bone, implants are 
directly osseointegrated into the bone. On the contrary, natural teeth are socketed into it 
via the periodontal ligament and the associated Sharpey’s fibres at its extremities. The 
lack of the periodontal ligament poses a number of biological “disadvantages” for the 
implant, compared to natural teeth. These include a reduced physical barrier against 
bacterial invasion into the submucosal tissue. Hence the peri-implant tissues present an 
“open wound” conformation, being more susceptible to an endogenous infection, as 
compared to periodontal tissues. The lack of periodontal ligament poses yet another 
disadvantage, which is the restricted blood supply. That is, in the case of the soft peri-
implant tissues, blood supply is facilitated via the supra-periosteal vessels and not via 
the periodontal ligament. This has subsequent effects on reduced presence of nutrients 
and cells of the immune system, which are needed to tackle the early stages of bacterial 
establishment and infection. Another potential drawback, which has not yet been 
extensively considered, is the reduced implant mobility. This may well impair the 
capacity of the implant to withstand occlusal and masticatory forces. 
 
Peri-implant microbiology 
The bacterial colonization of the surface starts already 30 min after implant insertion, 
and similar bacterial taxa can be identified on the implant after several months (8). The 
bacterial composition of the biofilm formed on implants closely resembles that of the 
neighboring teeth (9, 10). Hence, the microbial flora on natural teeth is a “reservoir” for 
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the biofilms that build-up around implants. In terms of initial (i.e. 4 weeks) subgingival 
colonization, the frequency of detection of different species is similar between natural 
teeth and implants. Nevertheless, the colonization pattern on implants appears to be 
initially slower than on natural teeth (11). 
The peri-implant microflora in health consists mainly of Gram-positive cocci and 
non-motile bacilli, and a limited number Gram-negative anaerobic species, resembling 
gingival health (12, 13). Nevertheless, the switch to peri-implant mucositis is associated 
with increased presence of cocci, motile bacilli and spirochetes, at proportions 
comparable to gingivitis (14). The transition to peri-implantitis is associated mainly with 
the emergence of Gram-negative, motile, and anaerobic species that are commonly 
found in periodontits (12, 15). Reportedly, the microbial flora of the peri-implant pockets 
resembles that of the neighboring periodontal pockets, while the three “red complex” 
species, namely Porphyromonas gingivalis, Tannerella forsythia and Treponema 
denticola, can be found at higher counts in peri-implantitis (9, 16, 17). Collectively, it 
appears that the qualitative composition of the biofilm microflora in peri-implantitis 
resembles that of periodontitis, which also implies that patients with active periodontal 
disease are at higher risk for developing peri-implantitis. Of note, submucosal biofilms 
obtained from peri-implantitis patients also yield bacteria that display in vitro resistance 
to one or more standard antibiotic treatments. These are most often Prevotella 
intermedia/nigrescens or Streptococcus constellatus (18). 
Nevertheless, a number of microorganisms have been identified in peri-
implantitis that may not be common to periodontitis. These include bacterial species 
such as Staphylococcus aureus, Staphylococcus epidermidis, Enterobacter aerogenes, 
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Enterobacter cloace, Escherichia coli, Helicobacter pylori, Peptostreptococcus micra, 
Pseudomonas spp, as well as Candida spp fungi (15, 19-25). Presence of S. aureus 
shortly after implant insertion can be confirmed even one year later (10). It has also 
been shown that up-to 18.6% of peri-implantitis lesions harbor aerobic Gram-negative 
bacilli, such as enteric rods and coliforms, or non-enteric rods, but the microbial burden 
may not fully correspond to disease severity (26). In a dog model of ligature-induced 
peri-implantitis, analysis of the microbial profiles after 3 months revealed an increase in 
total bacterial loads, predominated by an anaerobic Gram-negative microflora. The 
large variation of the microbial profiles hindered the interpretation of any association 
with disease progression (27). 
An important question raised with regards to peri-implant microbiota, is whether 
there are differences between fully and partially edentulous patients baring implants. 
Bacterial colonizers of healthy implants in fully edentulous individuals, appear to be 
similar to those found at healthy periodontal sites. In partially edentulous patients, the 
implant surface is colonized by the same species as the neighboring teeth, soft tissues, 
tongue and saliva (28, 29). Nevertheless, putative periodontal pathogens may be 
detected at higher proportions (30), prevalence and numbers (31), than in fully 
edentulous patients. Early studies indicated absence of detection of Aggregatibacter 
actinomycetemcomitans and P. gingivalis, which could allude to the subgingival niche 
being their source (32, 33). However, later studies indicated that these taxa can be 
detected in peri-implantitis occurring in fully edentulous patients (11, 16, 34), indicating 
that they are not harbored solely in the subgingival region. This means that they are 
also found at other niches of the oral cavity, such as the soft tissues or saliva, and they 
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are capable of colonizing the pristine implants or the peri-implant tissues of fully 
edentulous patients. Hence, bacterial species harbored in subgingival biofilms cannot 
be completely eliminated after tooth extraction, but may re-surface to colonize the 
implants. 
Considerable debate is made regarding the implant surface characteristics and its 
potential for biofilm formation. It is not clear if the microbial composition of a biofilm is 
affected by the physicochemical properties and texture characteristics of the implant 
surface. Higher roughness and higher free energy of the implant surface may favour 
biofilm formation (35), whereas peri-implantitis may occur earlier, with a faster and more 
extensive progression in implants with rougher surface (36-38). Nevertheless, it is also 
shown that abutments with different surface characteristics can influence neither biofilm 
formation on the implant surface, nor the extent and cellular composition of the resulting 
inflammatory lesion (39). Moreover, no implant system or surface type was found to be 
superior in terms of marginal bone preservation (40). However, one should consider that 
the implant surface, like the surface of natural teeth, is immediately covered by salivary 
mucoproteins, which are imperative for bacterial adhesion (41). These are genetically 
defined in each individual, and hence the same proteins that coat natural teeth and 
implants can be recognized by the same bacterial species. In this respect, potential 
differences in bacterial adhesion due to surface microstructure may partially be 
equilibrated by the mediating salivary pellicle (42). Hence, given the biological 
involvement of the pellicle, implant surface characteristics may not notably affect the 
initial stages of biofilm formation and composition. 
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Pathogenesis of peri-implant diseases 
Like in natural teeth, the accumulation of biofilm on the implant surface favors the 
initiation of tissue inflammation. At an initial stage, peri-implant mucositis is established, 
whereas spread of inflammation towards the supportive bone leads to peri-implantitis. 
The information available to-date comes mainly from comparative studies using human 
biopsy material from peri-implant mucosa, as well as experimental studies in Beagle 
dogs. Peri-implant mucositis is characterized by inflammation that culminates to an 
acanthotic epithelium, connective tissue loss, microvascular changes (43), and 
increased infiltration of T- and B-cells, neutrophils and macrophages (44, 45). These 
events are similar to gingivitis, but of greater magnitude (46-49). Of note, compared to 
the gingival mucosa, the peri-implant mucosa may present less Langerhan’s cells and 
more interstitial dendritic cells (50). The processing of the implant surface may also play 
a role in the inflammatory response of the adjacent peri-implant mucosal tissue. For 
instance, peri-implant mucosa biopsies obtained around acid-etched titanium healing 
caps exhibit greater microvessel density and inflammatory infiltrate, including higher 
number of T- and B-cells, compared to machined caps (51). These histopathological 
characteristics are commensurate with a more pronounced inflammatory response. 
The swift to peri-implantitis is characterized by even higher proportions of 
neutrophils, macrophages, T- and B-cells, than peri-implant mucositis or periodontitis 
(52, 53). A global transcriptome (microarray) analysis of human biopsies showed both 
shared and distinct gene expression “signatures” between peri-implantitis and 
periodontitis (54). Comparative experimental studies in Beagle dogs demonstrate loss 
of connective tissue and establishment of an inflammatory infiltrate in both periodontitis 
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and peri-implantitis (44, 48). However, the extent of the inflammatory infiltrate is greater 
in peri-implantitis, spreading towards the bone marrow (47). A larger proportion of 
neutrophils and osteoclasts is also observed in peri-implantitis, compared to 
periodontitis (38). 
The innate immune responses of the soft connective tissue may also differ 
between periodontitis and peri-implantitis. Granulation tissue from peri-implantitis sites 
exhibits higher mRNA expression of pro-inflammatory cytokines Interleukin(IL)-6, IL-8 
and tumor necrosis factor (TNF)-α, compared to matched tissue from periodontitis sites 
(55). Immunohistochemical comparison revealed that IL-1α staining was more prevalent 
in peri-implantitis tissue, while TNF-α was more prevalent in periodontitis tissue (56). 
Interestingly, fibroblasts isolated from peri-implantitis granulation tissue exhibited 
enhanced production of vascularization factors, matrix metalloproteases and 
complement receptor C1q, as well as reduced production of inhibitors of 
metalloproteases and growth factors that stimulate collagen synthesis, compared to 
fibroblasts from periodontitis granulation tissue. This specialized innate immune 
response of the peri-implant connective tissue may promote the migration and 
maintenance of inflammatory cell infiltrates into the affected site (57, 58). 
Hence, it appears that the sequence of inflammatory events and qualitative 
composition of the immune cells in peri-implantitis is rather similar to periodontitis (59). 
What differentiates peri-implantitis is the higher proportion of immune cells and 
associated inflammatory mediators, and the larger infiltrate that expands apically to the 
junctional epithelium towards the bone marrow (5, 60). 
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Although histopathologically peri-impant infections are quite well described, the 
molecular events that govern these processes are not yet fully characterized. Varying 
reports have attempted to associate specific genotypes of the immune response with 
peri-implantitis. There is some evidence that IL-1 polymorphisms, particularly in 
conjunction to smoking, may confer an increased risk for peri-implant bone loss or 
implant loss (61, 62), but this may not adequately reflect the produced levels of 
inflammatory mediators (63-65). Therefore, to-date no specific genotype or systemic 
inflammatory marker exists that can reliably indicate peri-implant disease progression or 
susceptibility (66).  
Nevertheless, on the level of the affected site, there is good merit to investigate the 
molecular content of peri-implant crevicular fluid (PICF), which is the inflammatory 
exudate of the peri-implant sulcus, in an analogous fashion as the gingival crevicular 
fluid (GCF) of natural teeth. Candidate molecules can be the ones already validated in 
periodontitis, such as the matrix metalloproteinases (67, 68), or the receptor activator of 
NF-kappaB ligand (RANKL) - osteoprotegerin (OPG) system (69, 70), which show a 
positive association with disease occurrence and severity (71, 72). An increasing 
stream of evidence shows the association of these factors with peri-implantitis (73-83). 
Moreover, higher concentrations of TNF-α, IL-17, IL-1β and nitric oxide are 
demonstrated in PICF of patients with peri-implantitis, compared to healthy controls (84-
87), whereas no differences were detected with regard to IL-6, IL-8, IL-10 (85), or 
prostaglandin E2 (88). These findings require further investigation, as they could 
potentially be used in the development of molecular diagnostic utilities and targets for 
the immuno-modulatory treatment of peri-implant diseases.  
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Synopsis of peri-implant diseases 
In summary, biofilms can form on implant surfaces, similarly to natural teeth, causing 
inflammation and subsequent destruction of the surrounding tissues. The microbial 
“reservoir” for the contamination of the implant surface includes neighboring teeth, 
periodontal pockets, saliva and soft oral tissues. Peri-implantitis appears to be a non-
specific mixed-flora infection, exhibiting similar microbiological characteristics to 
periodontitis, with the exception of staphylococci, peptostreptococci, enterobacteria and 
Candida spp. The sequence of immune-pathological events and qualitative composition 
of immune cells and inflammatory response in peri-implant infections is similar to that of 
periodontal infections. Nevertheless, the inflammatory tissue destruction in peri-
implantitis is faster and more extensive than in periodontitis. This could well account for 
structural differences in the conformation of the two tissue types. Hence peri-implant 
diseases are endogenous oral infections that have co-emerged with the routine 
application of osseointegrated dental implants, as part of restorative dental treatment. 
There is a clear need for a better understanding of these “contemporary” oral diseases, 
and a careful consideration prior to treatment planning, both by clinicians and patients. 
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